Odds and ends

September 2009
Marketing Health Services;Fall2009, Vol. 29 Issue 3, p5
Academic Journal
The article offers news briefs related to healthcare services in the U.S. American Medical Management Association asserts on poor cultural fit as the primary reason of physicians who decided to leave the medical profession. An increase from 89.7 million to 172.7 million was observed in the usage of statins in preventing heart diseases. Health systems should modify their work environment to attract young and motivated employees.


Related Articles

  • Statins to go OTC by June, say ministers. Doult, Bill; Polak, Monika; Baines, Emma // GP: General Practitioner;11/17/2003, p1 

    Statins could become available over the counter within the next six months, Great Britain Department of Health is expected to announce today. The Medicines and Healthcare Products Regulatory Agency and the Committee on Safety of Medicines are to consult on whether simvastatin, which came off...

  • JBS pushes for MOTs at age 40.  // Pulse;11/19/2005, Vol. 65 Issue 45, p3 

    The article reports on the new guidelines of the Joint British Societies that are aimed at identifying the huge numbers of extra patients who will now be eligible for statins in Great Britain. It advocates the need for general practitioners to assess every adult over forty for their risk of...

  • GP's fury as PCT dictates therapy.  // Pulse;11/15/2004, Vol. 64 Issue 45, p1 

    Reports that Norman Ellul, a general practitioner in Dagenham, Essex in England is furious that his primary care trust (PCT) is insisting that he uses simvastatin first-line in all patients eligible for statin treatment. Decision of Ellul to denounce the prescribing action plan of the PCT;...

  • Social deprivation and statin prescribing: a cross-sectional analysis using data from the new UK general practitioner ‘Quality and Outcomes Framework’. M. Ashworth; D. Lloyd; R. S. Smith; A. Wagner; G. Rowlands // Journal of Public Health;Vol. 29 Issue 1, p40 

    We aimed to study the relationship between the prescribing of lipid-lowering medication, social deprivation and other general practice characteristics. We conducted a cross-sectional survey of all general practices in England, 2004–05. For each practice, the following variables were...

  • Clinical: Statins lead the drive in primary CHD prevention. Minhas, Rubin // GP: General Practitioner;8/19/2005, p43 

    Discusses the impact of a new directive issued by NICE regarding treatment of congenital heart disease (CHD) patients in Great Britain on physicians. Information that NICE has established that treating patients at 20 per cent CHD risk or greater is a cost-effective use of NHS resources; Reasons...

  • Key issues for GPs: Q&A.  // Pulse;9/20/2004, Vol. 64 Issue 37, special section p6 

    Presents several queries on issues related to medical care. Details on the experiences of various general practitioners; Number of patients taking statin drugs; Causes of several diseases.

  • Call for statins on private prescription.  // GP: General Practitioner;2/16/2004, p5 

    The Great Britain government should allow general practitioners (GPs) to prescribe statins privately to their own patients rather than making the drugs available over-the-counter (OTC), researchers from the University of East Anglia, England have argued. Co-author of the research and GP at the...

  • The impact of cost-sharing schemes on drug compliance in Italy: evidence based on quantile regression. Atella, Vincenzo; Kopinska, Joanna // International Journal of Public Health;Apr2014, Vol. 59 Issue 2, p329 

    Objectives: In this article we investigate the causal effect of cost-sharing schemes on compliance with statins in a quantile regression framework. Methods: We use the health search CSD-LPD data, a longitudinal observational dataset containing computer-based patient records collected by Italian...

  • Generic statins save £2 billion.  // GP: General Practitioner;6/16/2006, p3 

    The article reports that general practitioners can dramatically cut NHS costs in England by using generic statins as first-line therapy for the majority of patients with hyperlipidaemia. About 85 percent of statin prescriptions in England are for simvastatin or atorvastatin. Most atorvastatin...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics